|
Patents Issue for Inotek Pharmaceuticals' Lead Clinical Candidates in Glaucoma and Contrast-Induced Nephropathy
S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
ES Cell International Announces Partnership with Large Pharma for assessment of GMP-Grade Stem Cell Lines
Human Stem Cell help mice in MS Research
|
